Dampness and Mould - WHO guidelines for indoor air quality - PRWeb

More documents

Recommendations

Info

114 WHO GUIDELINES FOR INDOOR AIR QUALITY: DAMPNESS AND MOULD Luczynska CM et al. (1989). A two-site monoclonal antibody ELISA for the quantification of the major Dermatophagoides spp. allergens, Der p I and Der f I. Journal of Immunological Methods, 118:227–235. Luosujärvi RA et al. (2003). Joint symptoms and diseases associated with moisture damage in a health center. Clinical Rheumatology, 22:381–385. Macher J, ed. (1999). Bioaerosols: assessment and control. Cincinnati, American Conference of Governmental Industrial Hygienists. Macher JM, Huang FY, Flores M (1991). A two-year study of microbiological indoor air quality in a new apartment. Archives of Environmental Health, 46:25– 29. Madigan M, Martinko J, eds. (2005). Brock biology of microorganisms, 11th ed. Upper Saddle River, NJ, Prentice Hall. Maier WC et al. (1997). Indoor risk factors for asthma and wheezing among Seattle school children. Environmental Health Perspectives, 105:208–214. Malmberg P et al. (1985). Exposure to microorganisms, febrile and airway-obstructive symptoms, immune status and lung function of Swedish farmers. Scandinavian Journal of Work, Environment and Health, 11:287–293. Martin TR, Frevert CW (2005). Innate immunity in the lungs. Proceedings of the American Thoracic Society, 2:403–411. Marx JJ et al. (1990). Cohort studies of immunologic lung disease among Wisconsin dairy farmers. American Journal of Industrial Medicine, 18:263–268. Mason CD et al. (2001). Effects of Stachybotrys chartarum on surfactant convertase activity in juvenile mice. Toxicology and Applied Pharmacology, 172:21– 28. Matheson MC et al. (2005). Changes in indoor allergen and fungal levels predict changes in asthma activity among young adults. Clinical and Experimental Allergy, 35:907–913. Mattson J, Carlson OE, Engh IB (2002). Negative influence on IAQ by air movement from mould contaminated constructions into buildings. In: Proceedings of Indoor Air 2002, 9th International Conference on Indoor Air Quality and Climate, Monterey, California, 30 June – 5 July 2002. Vol.1. Atlanta, American Society of Heating Refrigerating and Air Conditioning Engineers:764–769. Meklin T et al. (2007). Comparison of mold concentrations quantified by MSQPCR in indoor and outdoor air sampled simultaneously. Science of the Total Environment, 382:130–134. Mendell MJ, Smith AH (1990). Consistent pattern of elevated symptoms in airconditioned office buildings: a reanalysis of epidemiologic studies. American Journal of Public Health, 80:1193–1199. Mendell MJ et al. (1996). Elevated symptom prevalence associated with ventilation type in office buildings. Epidemiology, 7:583–589.
REFERENCES 115 Mendell MJ et al. (2003). Environmental risk factors and work-related lower respiratory symptoms in 80 office buildings: an exploratory analysis of NIOSH data. American Journal of Industrial Medicine, 43:630–641. Mendell MJ et al. (2006). Indicators of moisture and ventilation system contamination in US office buildings as risk factors for respiratory and mucous membrane symptoms: analyses of the EPA BASE data. Journal of Occupational and Environmental Hygiene, 3:225–233. Mendell MJ et al. (2007). Risk factors in heating, ventilating, and air–conditioning systems for occupant symptoms in US office buildings: the US EPA BASE Study. Berkeley, Lawrence Berkeley National Laboratory (Report LBNL-61870). Mendell MJ et al. (2008). Risk factors in heating, ventilating, and air-conditioning systems for occupant symptoms in US office buildings: the US EPA BASE study. Indoor Air, 18:301–316 Menzies D et al. (2000). Hospital ventilation and risk for tuberculous infection in Canadian health care workers. Canadian Collaborative Group in Nosocomial Transmission of TB. Annals of Internal Medicine, 133: 779–789. Menzies D et al. (2003). Effect of ultraviolet germicidal lights installed in office ventilation systems on workers’ health and wellbeing: double-blind multiple crossover trial. Lancet, 362:1785–1791. Meyer HW et al. (2005). Double blind placebo controlled exposure to moulds: exposure system and clinical results. Indoor Air, 15(Suppl. 10):73–80. Meyer V, Stahl U (2003). The influence of co-cultivation on expression of the antifungal protein in Aspergillus giganteus. Journal of Basic Microbiology, 43:68– 74. Michel O et al. (1996). Severity of asthma is related to endotoxin in house dust. American Journal of Respiratory and Critical Care Medicine, 154:1641–1646. Milanowski J (1998). Effect of inhalation of organic dust-derived microbial agents on the pulmonary phagocytic oxidative metabolism of guinea pigs. Journal of Toxicology and Environmental Health A, 53:5–18. Miller JD, Young JC (1997). The use of ergosterol to measure exposure to fungal propagules in indoor air. American Industrial Hygiene Association Journal, 58:39–43. Ministry of Social Affairs and Health (2003). Asumisterveysohje. Asuntojen ja muiden oleskelutilojen fysikaaliset, kemialliset ja mikrobiologiset tekijät. Sosiaali- ja terveysministeriö. Oppaita 1. [Health Protection Act. Instructions regarding physical, chemical and biological factors in housing. Guidebook No. 1]. Helsinki, Ministry of Social Affairs and Health (in Finnish). Mohamed N et al. (1995). Home environment and asthma in Kenyan schoolchildren: a case-control study. Thorax, 50:74–78. Mommers M et al. (2005). Indoor environment and respiratory symptoms in children living in the Dutch–German borderland. International Journal of Hygiene and Environmental Health, 208:373–381.
Page 1:
WHO GUIDELINES FOR INDOOR AIR QUALI
Page 4 and 5:
Keywords AIR POLLUTION, INDOOR - ad
Page 6 and 7:
Abstract Microbial pollution is a k
Page 8 and 9:
4. Health effects associated with d
Page 10 and 11:
VIII WHO GUIDELINES FOR INDOOR AIR
Page 12 and 13:
X Acknowledgements Preparation of t
Page 14 and 15:
XII Executive summary This document
Page 16 and 17:
XIV WHO GUIDELINES FOR INDOOR AIR Q
Page 18 and 19:
XVI WHO GUIDELINES FOR INDOOR AIR Q
Page 20 and 21:
2 WHO GUIDELINES FOR INDOOR AIR QUA
Page 22 and 23:
Page 24 and 25:
Page 26 and 27:
Page 28 and 29:
10 WHO GUIDELINES FOR INDOOR AIR QU
Page 30 and 31:
Page 32 and 33:
Page 34 and 35:
Page 36 and 37:
Page 38 and 39:
Page 40 and 41:
Page 42 and 43:
Page 44 and 45:
Page 46 and 47:
Page 49 and 50:
31 3. Moisture control and ventilat
Page 51 and 52:
MOISTURE CONTROL AND VENTILATION 33
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82: 63 4. Health effects associated wit
Page 83 and 84: HEALTH EFFECTS ASSOCIATED WITH DAMP
Page 111 and 112: 93 5. Evaluation of human health ri
Page 113: EVALUATION OF HUMAN HEALTH RISKS AN
Page 116 and 117: 98 WHO GUIDELINES FOR INDOOR AIR QU
Page 118 and 119: 100 WHO GUIDELINES FOR INDOOR AIR Q
Page 148 and 149: 130 HEALTH RISKS OF OZONE FROM LONG
Page 151 and 152: 133 Annex 1. Summary of epidemiolog
Page 153 and 154: ANNEX 1. SUMMARY OF EPIDEMIOLOGICAL
Page 183 and 184:
ANNEX 1. SUMMARY OF EPIDEMIOLOGICAL
Page 185 and 186:
Page 187 and 188:
Page 189 and 190:
Page 191 and 192:
Page 193 and 194:
Page 195 and 196:
Page 197 and 198:
Page 199 and 200:
Page 201 and 202:
Page 203 and 204:
Page 205 and 206:
Page 207 and 208:
Page 209 and 210:
Page 211 and 212:
Page 213 and 214:
Page 215 and 216:
Page 217 and 218:
Page 219 and 220:
Page 221 and 222:
Page 223 and 224:
Page 225 and 226:
Page 227 and 228:
Page 229 and 230:
Page 231 and 232:
Page 233 and 234:
215 Annex 2. Summary of in vitro an
Page 235 and 236:
ANNEX 2. SUMMARY OF IN VITRO AND IN
Page 237 and 238:
Page 239 and 240:
Page 241 and 242:
Page 243 and 244:
Page 245 and 246:
Page 248:
When sufficient moisture is availab
show all

Dampness and Mould - WHO guidelines for indoor air quality - PRWeb

Create successful ePaper yourself

Delete template?

Save as template?